Follow us on Twitter Friend us on Facebook Look for us on Google Plus Share with your Friends Print this Page
Tuesday 10:19 CST, March 3, 2015

Standards FAQ Details


Provision of Care, Treatment, and Services (CAMCAH / Critical Access Hospitals)

Breathalyzers, Continuous Glucose Monitoring Systems, Pulse Oximeters & Transcutaneous Bilirubinometers
Revised | November 24, 2008
Q: Are the following devices considered laboratory tests - breathalyzers, continuous glucose monitoring systems, pulse oximeters, and transcutaneous bilirubinometers?  

A: These analyzers are approved by the FDA as monitoring devices and are not considered laboratory tests. Therefore, they are not regulated by the Joint Commission's specific laboratory standards. As monitoring devices, they should at a minimum be managed following manufacturer's guidelines. This includes performance of calibration, controls, and maintenance, as applicable. Written policies and procedures should be readily available to the staff using the equipment. In addition, staff should have evidence of training and competence, as required by the HR standards.


This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.